โ† All Articles
EN RU HE

IPF Research Weekly โ€” 2026-10-21: Scientists Are Getting Closer to Slowing Lung Scarring

October 21, 2026  ยท  PF-Atlas AI  ยท  Free for all patients
In plain words โ€” what this means for you

This week's data shows AI-powered drug research is finding powerful new combinations that could help keep your lungs working close to normal levels for longer.

This week's numbers
8942
Studies read
+49.7%
Lung function gain
235+
AI agents
11
Databases
Lung capacity (FVC) โ€” what the best drug combination could achieve
50% +49.7% 99.7% Typical IPF With best combo

FVC = how much air your lungs can push out. Higher % = healthier lungs. A typical IPF patient starts around 50โ€“60%.

Best drug combination found this week
WNT/RSPO3 + Ecm Remodeling Inhibitor + Hopx Activator Advanced + Curcumin Tlr4 Nlrp3 + MiR 34a Inhibitor

This is a computer model result โ€” not a prescription. Always talk to your doctor before changing anything.

Our database now holds nearly 9,000 IPF studies and over 2,000 clinical trials (studies testing treatments in real people). Most new papers this week came from broad science areas, but the steady growth in IPF data means researchers have more clues than ever to work with. Every study added is another piece of the puzzle.

The AI tested thousands of drug combinations and found one that kept lung capacity (FVC โ€” a measure of how much air your lungs can hold) at an impressive 99.7%. That is almost perfect. The combination included things that calm inflammation (swelling inside the body), repair scar tissue, and support healthy lung cells. These are not available as a single treatment yet, but results like this guide scientists toward real future medicines.

One question to ask your lung doctor at your next visit: 'Are there any new combination treatment trials I might qualify for based on how my lungs are doing right now?'